EDWARD VECCHIONE: Open Payments
NPI 1760440929 · NUTLEY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 57 payments from 13 companies in 2025. Trend: 2023 $1,330 · 2024 $1,233 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $238 |
| AstraZeneca Pharmaceuticals LP | 12 | $210 |
| Lilly USA, LLC | 7 | $108 |
| PFIZER INC. | 4 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Amgen Inc. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| Braeburn Inc. | 3 | $47 |
| Exact Sciences Corporation | 2 | $45 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
Products named: Ozempic, BREZTRI, JARDIANCE, MOUNJARO, XIFAXAN, OTEZLA, BRIXADI, PREVNAR 20.
Industry payments across NJ — which companies pay providers there.
